MSD’s pneumococcal vaccine candidate shows promise in paediatric studies
Investigational 15-valent pneumococcal conjugate vaccine consists of pneumococcal polysaccharides from 15 serotypes
Read More
Tag: pneumococcal conjugate vaccine
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
